These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 10793238)

  • 1. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography.
    Krause KH; Dresel SH; Krause J; Kung HF; Tatsch K
    Neurosci Lett; 2000 May; 285(2):107-10. PubMed ID: 10793238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment.
    Dresel S; Krause J; Krause KH; LaFougere C; Brinkbäumer K; Kung HF; Hahn K; Tatsch K
    Eur J Nucl Med; 2000 Oct; 27(10):1518-24. PubMed ID: 11083541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of 99mTc-TRODAT-1 SPECT to predict clinical response to methylphenidate treatment in adults with attention deficit hyperactivity disorder.
    la Fougère C; Krause J; Krause KH; Josef Gildehaus F; Hacker M; Koch W; Hahn K; Tatsch K; Dresel S
    Nucl Med Commun; 2006 Sep; 27(9):733-7. PubMed ID: 16894328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic imaging study with [Tc-
    Akay AP; Kaya GÇ; Kose S; Yazıcıoğlu ÇE; Erkuran HÖ; Güney SA; Oğuz K; Keskin D; Baykara B; Emiroğlu Nİ; Eren MŞ; Kızıldağ S; Ertay T; Özsoylu D; Miral S; Durak H; Gönül AS; Rohde LA
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():294-300. PubMed ID: 29684537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenidate DAT binding in adolescents with Attention-Deficit/ Hyperactivity Disorder comorbid with Substance Use Disorder--a single photon emission computed tomography with [Tc(99m)]TRODAT-1 study.
    Szobot CM; Shih MC; Schaefer T; Júnior N; Hoexter MQ; Fu YK; Pechansky F; Bressan RA; Rohde LA
    Neuroimage; 2008 Apr; 40(3):1195-201. PubMed ID: 18282769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated striatal dopamine transporter in a drug naive patient with Tourette syndrome and attention deficit/ hyperactivity disorder: positive effect of methylphenidate.
    Krause KH; Dresel S; Krause J; Kung HF; Tatsch K; Lochmüller H
    J Neurol; 2002 Aug; 249(8):1116-8. PubMed ID: 12420715
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD.
    Krause J; la Fougere C; Krause KH; Ackenheil M; Dresel SH
    Eur Arch Psychiatry Clin Neurosci; 2005 Dec; 255(6):428-31. PubMed ID: 16091862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular imaging genetics of methylphenidate response in ADHD and substance use comorbidity.
    Szobot CM; Roman T; Hutz MH; Genro JP; Shih MC; Hoexter MQ; Júnior N; Pechansky F; Bressan RA; Rohde LA
    Synapse; 2011 Feb; 65(2):154-9. PubMed ID: 20593420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.
    Crunelle CL; van den Brink W; Veltman DJ; van Emmerik-van Oortmerssen K; Dom G; Schoevers RA; Booij J
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1714-23. PubMed ID: 23731497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Searching for a neurobiological basis for self-medication theory in ADHD comorbid with substance use disorders: an in vivo study of dopamine transporters using (99m)Tc-TRODAT-1 SPECT.
    Silva N; Szobot CM; Shih MC; Hoexter MQ; Anselmi CE; Pechansky F; Bressan RA; Rohde LA
    Clin Nucl Med; 2014 Feb; 39(2):e129-34. PubMed ID: 23856832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attention deficit/hyperactivity disorder: is there a correlation between dopamine transporter density and cerebral blood flow?
    da Silva N; Szobot CM; Anselmi CE; Jackowski AP; Chi SM; Hoexter MQ; Anselmi OE; Pechansky F; Bressan RA; Rohde LA
    Clin Nucl Med; 2011 Aug; 36(8):656-60. PubMed ID: 21716015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo imaging of serotonin transporters with [99mTc]TRODAT-1 in nonhuman primates.
    Dresel SH; Kung MP; Huang X; Plössl K; Hou C; Shiue CY; Karp J; Kung HF
    Eur J Nucl Med; 1999 Apr; 26(4):342-7. PubMed ID: 10199939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological effects of dopaminergic drugs on in vivo binding of [99mTc]TRODAT-1 to the central dopamine transporters in rats.
    Dresel SH; Kung MP; Plössl K; Meegalla SK; Kung HF
    Eur J Nucl Med; 1998 Jan; 25(1):31-9. PubMed ID: 9396872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD).
    Vles JS; Feron FJ; Hendriksen JG; Jolles J; van Kroonenburgh MJ; Weber WE
    Neuropediatrics; 2003 Apr; 34(2):77-80. PubMed ID: 12776228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate.
    Cheon KA; Ryu YH; Kim JW; Cho DY
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):95-101. PubMed ID: 15572278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
    Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment.
    del Campo N; Fryer TD; Hong YT; Smith R; Brichard L; Acosta-Cabronero J; Chamberlain SR; Tait R; Izquierdo D; Regenthal R; Dowson J; Suckling J; Baron JC; Aigbirhio FI; Robbins TW; Sahakian BJ; Müller U
    Brain; 2013 Nov; 136(Pt 11):3252-70. PubMed ID: 24163364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine transporter concentration is reduced in asymptomatic Machado-Joseph disease gene carriers.
    Yen TC; Tzen KY; Chen MC; Chou YH; Chen RS; Chen CJ; Wey SP; Ting G; Lu CS
    J Nucl Med; 2002 Feb; 43(2):153-9. PubMed ID: 11850478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of dopamine transporter blockade by methylphenidate: first in vivo investigation using [123I]FP-CIT and a dedicated small animal SPECT.
    Nikolaus S; Wirrwar A; Antke C; Arkian S; Schramm N; Müller HW; Larisch R
    Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):308-13. PubMed ID: 15791440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal dopamine transporter availability and DAT-1 gene in adults with ADHD: no higher DAT availability in patients with homozygosity for the 10-repeat allele.
    Krause J; Dresel SH; Krause KH; La Fougère C; Zill P; Ackenheil M
    World J Biol Psychiatry; 2006; 7(3):152-7. PubMed ID: 16861140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.